Samil PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 1/6
Samil PharmaceuticalLtd has a total shareholder equity of ₩127.8B and total debt of ₩174.3B, which brings its debt-to-equity ratio to 136.3%. Its total assets and total liabilities are ₩370.7B and ₩242.9B respectively. Samil PharmaceuticalLtd's EBIT is ₩6.5B making its interest coverage ratio 1.8. It has cash and short-term investments of ₩906.1M.
Key information
136.3%
Debt to equity ratio
₩174.27b
Debt
| Interest coverage ratio | 1.8x |
| Cash | ₩906.14m |
| Equity | ₩127.83b |
| Total liabilities | ₩242.85b |
| Total assets | ₩370.68b |
Recent financial health updates
Recent updates
There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump
Mar 30
Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality
Mar 21Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment
Mar 11Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?
Feb 15
Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?
Jan 20Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend
Dec 24Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment
Dec 09What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?
Nov 18Financial Position Analysis
Short Term Liabilities: A000520's short term assets (₩81.1B) do not cover its short term liabilities (₩168.7B).
Long Term Liabilities: A000520's short term assets (₩81.1B) exceed its long term liabilities (₩74.2B).
Debt to Equity History and Analysis
Debt Level: A000520's net debt to equity ratio (135.6%) is considered high.
Reducing Debt: A000520's debt to equity ratio has increased from 118.9% to 136.3% over the past 5 years.
Debt Coverage: A000520's debt is not well covered by operating cash flow (6.7%).
Interest Coverage: A000520's interest payments on its debt are not well covered by EBIT (1.8x coverage).